 Hydroxybutyrates
"Hydroxybutyrates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Salts and esters of hydroxybutyric acid.
| Descriptor ID |
D006885
|
| MeSH Number(s) |
D02.241.081.114.937 D02.241.511.429 D10.251.400.143.781
|
| Concept/Terms |
Hydroxybutyric Acids- Hydroxybutyric Acids
- Hydroxybutyric Acid Derivatives
- Acid Derivatives, Hydroxybutyric
|
Below are MeSH descriptors whose meaning is more general than "Hydroxybutyrates".
Below are MeSH descriptors whose meaning is more specific than "Hydroxybutyrates".
This graph shows the total number of publications written about "Hydroxybutyrates" by people in this website by year, and whether "Hydroxybutyrates" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2005 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hydroxybutyrates" by people in Profiles.
-
Cheung J, Lucey BP, Duntley SP, Darken RS. ?-Hydroxybutyric acid-induced electrographic seizures. J Clin Sleep Med. 2014 Jul 15; 10(7):811-2.
-
Yeoman CJ, Thomas SM, Miller ME, Ulanov AV, Torralba M, Lucas S, Gillis M, Cregger M, Gomez A, Ho M, Leigh SR, Stumpf R, Creedon DJ, Smith MA, Weisbaum JS, Nelson KE, Wilson BA, White BA. A multi-omic systems-based approach reveals metabolic markers of bacterial vaginosis and insight into the disease. PLoS One. 2013; 8(2):e56111.
-
Cohen MJ, Serkova NJ, Wiener-Kronish J, Pittet JF, Niemann CU. 1H-NMR-based metabolic signatures of clinical outcomes in trauma patients--beyond lactate and base deficit. J Trauma. 2010 Jul; 69(1):31-40.
-
Serkova NJ, Christians U. Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood. Ther Drug Monit. 2005 Dec; 27(6):733-7.
-
Elkayam O, Yaron I, Shirazi I, Judovitch R, Caspi D, Yaron M. Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann Rheum Dis. 2003 May; 62(5):440-3.
-
Hausen B, Boeke K, Berry GJ, Gummert JF, Christians U, Morris RE. Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model. Transplantation. 1999 Feb 15; 67(3):354-9.
-
Poggetti RS, Moore EE, Moore FA, Koike K, Tuder R, Anderson BO, Banerjee A. Quantifying oxidative injury in the liver. Am J Physiol. 1995 Mar; 268(3 Pt 1):G471-9.
-
Vernon RG, Faulkner A, Hay WW, Calvert DT, Flint DJ. Insulin resistance of hind-limb tissues in vivo in lactating sheep. Biochem J. 1990 Sep 15; 270(3):783-6.
-
Brass EP, Tahiliani AG, Allen RH, Stabler SP. Coenzyme A metabolism in vitamin B-12-deficient rats. J Nutr. 1990 Mar; 120(3):290-7.
-
Hiatt WR, Regensteiner JG, Wolfel EE, Ruff L, Brass EP. Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state. J Clin Invest. 1989 Oct; 84(4):1167-73.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|